Quince Therapeutics

QNCXNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$30.715 M

$30.20 +2.23%

Close of 7 Aug 2026

Revenue

—

Not reported

Earnings

-$84.0M

Loss-making

Shares outstanding

163,007,943

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances) — ranked by market cap

All 160 →

#136Aligos TherapeuticsALGS$34.6M
#137Estrella ImmunopharmaESLA$31.1M
#138Quince TherapeuticsQNCX$30.7M
#139Cel SciCVM$30.1M
#140Evaxion A/SEVAX$25.9M

Where these numbers come from

Share counts and financials for Quince Therapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.